Search | flexartsocial.com

Search

Veranstaltungen

David Cracc @davidcracc ein Foto hinzugefügt in Health
2025-03-07 07:49:56 · Translate ·

Empowering Change Through Innovation in NASH Treatment

A Breakthrough for NASH Patients The approval of Rezdiffra (resmetirom) marks a groundbreaking moment in the ongoing fight against Nonalcoholic Steatohepatitis (NASH), a chronic liver condition affecting millions worldwide. NASH, a progressive form of nonalcoholic fatty liver disease, is characterized by inflammation and damage to the liver, often leading to cirrhosis or liver failure....

0 Kommentare ·0 Anteile ·979 Ansichten ·0 Vorschau

Please log in to like, share and comment!
David Cracc @davidcracc ein Foto hinzugefügt in Health
2025-03-07 05:40:32 · Translate ·

Madrigal’s Rezdiffra Breakthrough Transforms NASH Treatment, Leading the Way for Next-Gen Therapies

Nonalcoholic steatohepatitis (NASH) has long been a challenging liver disease with no FDA-approved treatments—until now. Madrigal Pharmaceuticals' Rezdiffra (resmetirom) marks a significant milestone, becoming the first therapy to gain regulatory approval for NASH treatment. As a selective thyroid hormone receptor-beta (THR-β) agonist, Rezdiffra effectively targets...

0 Kommentare ·0 Anteile ·1KB Ansichten ·0 Vorschau

Please log in to like, share and comment!
David Cracc @davidcracc ein Foto hinzugefügt in Health
2025-03-09 17:47:17 · Translate ·

Madrigal’s Rezdiffra: A Landmark Discovery Shaping the Future of NASH Treatment

A Groundbreaking Approval for NASH Treatment The approval for NASH treatment has long been a significant unmet need in the medical world, with millions of individuals suffering from Nonalcoholic Steatohepatitis (NASH) worldwide. NASH is a progressive liver disease characterized by inflammation, fat buildup, and liver damage that can eventually lead to cirrhosis and liver failure. Until...

0 Kommentare ·0 Anteile ·758 Ansichten ·0 Vorschau

Please log in to like, share and comment!
David Cracc @davidcracc ein Foto hinzugefügt in Health
2024-12-18 09:26:11 · Translate ·

NASH Drug Development Landscape: Recent Breakthroughs and Innovations

Nonalcoholic Steatohepatitis (NASH) is a liver disease characterized by inflammation and damage to the liver, which can progress to cirrhosis, liver failure, or even liver cancer if left untreated. The increasing global prevalence of NASH, largely driven by rising rates of obesity and diabetes, has prompted significant advancements in the development of NASH treatment options. Despite...

0 Kommentare ·0 Anteile ·3KB Ansichten ·0 Vorschau

Please log in to like, share and comment!